Cibc Private Wealth Group, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 14 shares of MDGL stock, worth $5,772. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 1,050
98.67%
Holding current value
$5,772
Previous $323,000
98.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MDGL
# of Institutions
369Shares Held
23.3MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$904 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$862 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$822 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$815 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$774 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $7.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...